Overview

A Study of A-101 Topical Solution in Subjects With Dermatosis Papulosa Nigra

Status:
Completed
Trial end date:
2019-01-08
Target enrollment:
Participant gender:
Summary
Evaluate the safety and efficacy of hydrogen peroxide, A-101 Solution 40% for the treatment of DPN lesions on subjects with a Fitzpatrick Skin Type of 5 or 6.
Phase:
Phase 2
Details
Lead Sponsor:
Aclaris Therapeutics, Inc.
Treatments:
Pharmaceutical Solutions